Replies to post #59240 on NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

chinatown1980,

The need to fund manufacturing infrastructure and expansion should be expected to be ongoing. Whether or not this means more dilution before major validation news depends on when validation takes place and whether or not a source of income is generated during ramp up and any additional trials or not. We are hoping that some of a certain infusion of $250,000,000 into immunotherapy research will find its way to help fund DCVax trials at UCLA or MD Anderson and or that a collaborative combination trial will be announced but these won't take care of day to day contractual obligations necessarily so.. we wait for validation with the understanding that if Mr. Woodford buys more on the open market towards a critical ownership point, at some point more dilution will be needed to accommodate it for Linda to maintain control. Hopefully this is all worked out beforehand amicably.